Re: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

Journal of the National Cancer Institute

Volumn 86, Issue 23, 1994, Pages 1798-1799

  Cantor, Alan B ^a   Shuster, Jonathan J ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; METHODOLOGY; NEOPLASM; NOTE; PROGNOSIS; REGRESSION ANALYSIS;

HUMAN; NEOPLASMS; PROGNOSIS; REGRESSION ANALYSIS; RESEARCH DESIGN; STATISTICS;

EID: 0028767938     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.23.1798-a     Document Type: Letter

References (4)

1. Altman DG, Lausen B, Sauerbrei W, et al: Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829-835, 1994.
2. Shuster JJ, McWilliams NB, Castleberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive pardoning study. Am J Clin Oncol 15:295-303, 1992.
3. Trueworthy R, Shuster J, Look T, et al: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10:4,606-613, 1992.
4. Harris MB, Shuster JJ, Carroll A, et al: Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 79:3316-3324, 1992.